Cite

HARVARD Citation

    van Vollenhoven, R. et al. (2020). Long-term safety and limited organ damage in patients with systemic lupus erythematosus treated with belimumab: a Phase III study extension. Rheumatology. pp. 281-291. [Online]. 
  
Back to record